top of page

What is Semaglutide?


Semaglutide is a medication that is used for the treatment of type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by mimicking the action of a hormone called GLP-1 in the body. This hormone helps to regulate blood sugar levels by increasing insulin production and decreasing glucagon (a hormone that raises blood sugar levels) production.

Semaglutide is taken once a week by subcutaneous injection, and it is an alternative to daily injections of GLP-1 receptor agonists. It has been shown to be effective in lowering blood sugar levels, reducing hemoglobin A1c (a measure of long-term blood sugar control) and also promoting weight loss.

One of the benefits of Semaglutide is that it helps reduce the risk of cardiovascular disease in people with type 2 diabetes. Studies have shown that Semaglutide can lower the risk of heart attacks, strokes and death from cardiovascular disease.

Semaglutide is also been studied as an obesity treatment, and has shown to be effective in promoting weight loss by reducing appetite, increasing feelings of fullness, and promoting fat loss.

It's important to note that, like any medication, semaglutide may cause side effects and may not be suitable for everyone. The most common side effects are nausea, diarrhea, and vomiting. However, these side effects are usually mild and go away within the first few weeks of treatment.

It's important to talk to your healthcare provider about the benefits and risks of semaglutide before starting treatment. They can help you determine if semaglutide is the right option for you and help you manage any side effects.

In summary, Semaglutide is a once-weekly injectable medication that helps lower blood sugar levels and promote weight loss in people with type 2 diabetes. It also reduces the risk of cardiovascular disease. It's important to talk to a healthcare professional before starting treatment and to closely monitor your blood sugar levels while on semaglutide.


bottom of page